Aleafia Health (TSX: ALEF) (OTCQX: ALEAF) (FRA: ARAH) announced this morning that the company has received multiple export permits from Health Canada. These export permits will allow Aleafia to ship cannabis products internationally. Aleafia expects to complete its first international shipment of branded cannabis oils to Australia within the next month. The cannabis oil will be distributed by Australian Licensed Producer CannaPacific Pty. Aleafia owns a 10% stake in CannaPacific.
Aleafia’s new Health Canada permits will allow the company to export and ship branded cannabis oils, sprays, and drops to the Australian and international markets. The company has already obtained the corresponding medical cannabis import permits from the Australian Government’s Department of Health.
“The receipt of Health Canada Export Permits enables Aleafia Health to sell high-margin, value-added cannabis products across international borders for the first time, representing a major milestone as we augment our global distribution platform,” said Aleafia Health Chairman Julian Fantino. “We continue to prove the international viability of our highly differentiated cannabis health and wellness ecosystem with products, clinic operations, education, and distribution. With among the largest cultivation and extraction footprints in Canada coming online, we will continue to look to new international markets.”
“This is such a tremendous milestone for CannaPacific. Our relationship with Aleafia Health continues to accelerate our strategic vision of leadership in the Australasian medical cannabis market,” said CannaPacific CEO Joshua Dennis. “We have the facility, the proven management team, and now the product portfolio to continue executing towards our goal.”
Source: Aleafia Health YouTube
Investors looking for additional information on Aleafia Health are encouraged to visit the company’s website here.
About Aleafia Health:
Aleafia Health is a leading, vertically integrated cannabis health and wellness company with four primary business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience with e-commerce, retail distribution and provincial supply agreements.
Aleafia Health owns three major cannabis product & cultivation facilities, two of which are licensed and operational including the first large-scale outdoor cultivation facility in Canada. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners, and educators.
Innovation is at the heart of Aleafia Health’s competitive advantage. The Company maintains a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy. The Company is committed to creating sustainable shareholder value and has been named the 2019 top performing company of the year by the TSX Venture Exchange, prior to graduation to the TSX.
Aleafia Health (TSXV: ALEF) 6 Month Chart
Aleafia Health (TSXV: ALEF) Technical Analysis Signal
Move over Canopy. The world’s largest cannabis company is set to IPO in less than 30 days.
Get the full details here so you don’t miss out on the next potential 10 bagger.